- Filed
- Feb 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 12, 2025 | 15.37K sh |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $409.8K |
| Long Term Debt | Q2 2025 · Jun 30, 2024 | $399.33K |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $4.15M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $3.79M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $4.24M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $3.85M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $17.98K |
| Current Assets | Q2 2025 · Jun 30, 2024 | $25.44K |
| Total Assets | Q2 2025 · Dec 31, 2024 | $78.53K |
| Total Assets | Q2 2025 · Jun 30, 2024 | $72.37K |
| Shares Diluted restated | Q2 2025 · Dec 31, 2023 | 397 sh |
| Shares Diluted restated | Q2 2025 · Dec 31, 2023 | 290 sh |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | −$572.34K |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | −$3.56M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | −$2.99M |
| Stockholders Equity | Q2 2025 · Jun 30, 2023 | −$3.12M |
| Eps Diluted restated | Q2 2025 · Dec 31, 2023 | −$1,559.55 |
| Eps Diluted restated | Q2 2025 · Dec 31, 2023 | −$3,835.55 |
| Eps Basic restated | Q2 2025 · Dec 31, 2023 | −$1,559.55 |
| Eps Basic restated | Q2 2025 · Dec 31, 2023 | −$3,835.55 |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $318.19K |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $712.01K |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $114.02K |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $130.26K |
| Net Income | Q2 2025 · Dec 31, 2023 | −$584.38K |
| Net Income | Q2 2025 · Dec 31, 2023 | −$935.25K |
| Net Income | Q2 2025 · Sep 30, 2023 | −$350.87K |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$438.06K |
| Operating Income | Q2 2025 · Dec 31, 2023 | −$855.28K |